A.M. Hissink

Species and Strain Differences in the Hepatic Cytochrome P450-Mediated Biotransformation of 1,4-Dichlorobenzene

A.M. Hissink, Maroeska Oudshoorn, Ben van Ommen et al. · Toxicology and Applied Pharmacology · 1997 · 33 citations

Medicine, Pharmacology, Toxicology +14

Kinetics and metabolism of 1,4-dichlorobenzene in male Wistar rats: no evidence for quinone metabolites

A.M. Hissink, Ramon Dunnewijk, Ben van Ommen et al. · Chemico-Biological Interactions · 1997 · 32 citations

Pharmacy, Pharmacokinetics, Toxicology +8

Model studies for evaluating the neurobehavioral effects of complex hydrocarbon solvents

A.M. Hissink, Jacob Krüse, B.M. Kulig et al. · NeuroToxicology · 2007 · 24 citations

Pharmacy, Neuroscience, Toxicology +16

The Use of Biokinetics and in Vitro Methods in Toxicological Risk Evaluation

Bas J. Blaauboer, Martin K. Bayliss, José V. Castell et al. · Alternatives to Laboratory Animals · 1996 · 24 citations

Pharmacy, Pharmacokinetics, Toxicology +12

A physiologically-based pharmacokinetic(PB-PK) model for ethylene dibromide: relevance of extrahepatic metabolism

A.M. Hissink, Lars W. Wormhoudt, Philip J. Sherratt et al. · Food and Chemical Toxicology · 2000 · 23 citations

Pharmacy, Pharmacokinetics, Pharmacology +14